Articles On Resapp Health (ASX:RAP)

The Greens want the current temporary funding system for telehealth made permanent, echoing calls from industry over the last two months. Telehealth has been funded by the Medicare Benefits Scheme (MBS) for a very limited group of people si...

Fortunes were to be made in ASX health stocks during March and April as investors looked for salvation from the COVID-19 pandemic fears rocking markets. However, once the two biggest health stocks Resmed (ASX:RMD) and CSL (ASX:CSL) are take...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Clinical t...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Clinical t...

18 Jun 2020 - Digital health company, ResApp Health (ASX:RAP) has signed a memorandum of understanding with global health product manufacturer, RB.

S&P Dow Jones Indices has announced the quarterly rebalance of the entire S&P/ASX index hierarchy, revealing which companies have been added and removed. This review of the ASX’s major indices – the S&P/ASX 20, 50, 100, 200, 300...

Can you tell whether a person has COVID-19 by their cough? Research says it’s highly unlikely you, or even a professional, can accurately identify the origin of wheezes, hems and heaves, and whether it’s the flu or just a drink that’s gone...

Optimism is returning to the sleep apnoea market as Somnomed (ASX:SOM) says the nightmares that prompted a $15.5m capital raising in March haven’t returned. In fact, “trading has been better than expected and forecast” since the company rai...

ResApp Health (ASX:RAP) says its ResAppDx-EU smartphone-based acute respiratory diagnostic test has been under evaluation at a federal government-funded COVID-19 respiratory clinic in Brisbane for the past month.

ResApp Health (ASX:RAP), a digital health company developing smartphone applications for the diagnosis and management of respiratory disease, says it has received a set of final design files, reports and supporting documents for the...

06 May 2020 - Digital health company ResApp Health (ASX:RAP) has received a set of final design files, reports and supporting documents for the handheld and wearable devices under …

As we approach the middle of 2020, the investment environment surrounding the fallout from the COVID-19 pandemic remains complex. Along with threats, there will be plenty of opportunities. And it’s against that backdrop that this week marke...

VidCon is Stockhead’s new virtual conference series, bringing you expert insights, panel discussions and presentations on the most interesting and relevant investment sectors from leading analysts, listed small caps and industry participant...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   This week’s three big themes...

Digital health company ResApp Health (ASX: RAP) has unveiled a new smartphone app that can be used in the home to assess a person’s risk of obstructive sleep apnoea. According to ResApp, the ‘SleepCheck’ app uses clinically accurate algorit...

Digital health company ResApp Health (ASX: RAP) has inked a binding deal to integrate its ResAppDx-EU diagnostic test into Coviu’s telehealth platform to enable clinicians to perform respiratory assessments remotely. ResAppDx-EU is a smartp...

In the last two weeks medical professionals in Australia have been forced online, in a radical upheaval of the health sector. On Sunday, the federal government went even further, opening telehealth services “to every Australian anywhere” in...

The coronavirus-induced market carnage of the last few weeks has rattled plenty of investor nerves. But as with any major correction, some industries feel the brunt of the impact while for others, the dramatic shift presents an opportunity....

Two digital health companies have joined forces to expand access to telehealth services targeted specifically at diagnosing respiratory diseases. ResApp Health (ASX: RAP) will integrate its acute respiratory diagnostic test ResAppDx-EU in...

Typically patients with HIV need to stay on treatment for life but that may no longer be the case if Biotron’s (ASX:BIT) anti-HIV therapy stacks up. The biotech has found that its anti-HIV therapy can restore immune functions in HIV patient...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The S&P/ASX 200 index is tumbling notably lower this afternoon. At the time of writing the benchmark index is down 2.15% to 5,811.9 points. Four shares that have fallen more than most today are listed below. Here’s why they are sinking...

The ResApp Health Ltd (ASX: RAP) share price has been one of the worst performers on the Australian share market on Wednesday. The digital health company’s shares were down as much as 67% in morning trade, They have recovered slightly this...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Australian health care sector is one of the fastest growing, dynamic and highly diversified sectors having enormous potential to generate substantial returns for the Australian economy. A broad range of companies, from companies engaged in...

While Investing in stock market, everyone comes up with a mindset of getting higher returns with limited amount of investment and in a shorter span of time. This leads them to look for cheaper stocks. However, this practice sometimes fails....

Air pollution is a growing problem that in recent days has reached our own backyard. Because of the bushfires in surrounding areas, Sydney’s air has been ranked the ninth worst in the world. It’s not the first time in history it’s happened...

Australian healthcare system is vast, and it has many healthcare service providers with their roots in drug development, imaging solutions, pathology, medical devices, distribution, among other areas. The healthcare system in Australia is r...

In afternoon trade the S&P/ASX 200 index is on course to record yet another gain. At the time of writing the benchmark index is up 0.25% to 6,867 points. Four shares that are climbing more than most today are listed below. Here’s why t...

The Volpara Health Technologies Ltd (ASX: VHT) share price has been a strong performer today. In afternoon trade the healthcare technology company’s shares are up almost 4% to $1.87. Why is the Volpara share price racing higher? Investors...

The powerful US Food and Drug Administration (FDA) has cleared a body scanner to check whether a person has protein calorie malnutrition, a risk of the highly popular Keto diet. Impedimed’s (ASX:IPD) scanner SOZO can tell how much and where...

ResApp Health (ASX: RAP) has entered an agreement to have its acute respiratory diagnostic test integrated into Australia’s leading telehealth software platform Coviu. According to ResApp, the integration of its diagnostic technology ResApp...

In morning trade the ResApp Health Ltd (ASX: RAP) share price is storming higher. At the time of writing the digital health company’s shares are up 13% to 30.5 cents. Why is the ResApp share price racing higher? Investors have been buying...

In the health care industry, there is usually an urgent requirement to find innovative ways to improve a patient’s health condition because of the rise in aging population and increasing chronic diseases across the world. Introduction of di...

15 Nov 2019 - Digital health company ResApp Health (ASX:RAP) has penned an agreement which grants Sanofi an exclusive license to use the outcomes generated under the Startup Creasp…

The ResApp Health Ltd (ASX: RAP) share price is on course to end the week on a positive note. At the time of writing the digital health company’s shares are up over 7% to 29 cents. Why is the ResApp share price racing higher? This morning...

The TechKnow Invest Roadshow provides retail and institutional investors, as well as brokers, an opportunity to learn more about a range of tech and biotech companies. More than 20 companies will present at the conference on Thursday, Octob...

On Monday the Australian share market started the week with the smallest of gains. Despite this, some ASX shares charged notably higher. Some even managed to climb to 52-week highs or better. Three that achieved this milestone are listed b...

Australia’s health care system has been the global benchmark for past decades due to its excellent medical research and health infrastructure. It is amongst the most comprehensive health care systems in the world offering a variety of servi...

Special Report: The inaugural Biotech Luncheon in Perth launched with a bang, with more than 150 guests attending the event last week. Hosted by industry entrepreneur Brian Leedman, the luncheon was established to raise awareness of, and bu...

Strong gains among selected life science shares is fuelling optimism the sector may have further to run. Life sciences stocks are involved in things like biotech, genetics, pharmaceuticals and medical devices. In a low growth earnings envir...

With the market returning to form on Monday after a few wobbles last week, a good number of shares raced notably higher yesterday. Some even managed to climb to 52-week highs or better. Three which achieved this milestone are listed below....

Digital health company ResApp Health (ASX: RAP) has been given an operational boost by a German health program backed by pharmaceutical giants Roche and Sanofi, while also securing Therapeutic Goods Administration approval for its respirato...

04 Oct 2019 - Digital health company, ResApp Health (ASX:RAP) has been selected to join the Startup Creasphere Digital Health Program in Munich.

The WA investment community will turn its attention to healthcare next Thursday, when the annual Biotech Lunch takes place in Perth. Hosted by industry entrepreneur Brian Leedman, the luncheon will provide a forum for brokers and investors...

On Stockhead today: are semiconductors about to pick up again, California’s first pot cafe opens, biotech losers’ remarkable comeback, and angel investment firm Investible closes with $22m round. But first:   The day ahead Today the Austral...

The Australian benchmark index S&P/ASX200, last traded on 2 October 2019, at 6639.9 points, down by 1.5 percent from the prior close. Also, S&P/ASX200 Health Care (Sector) last traded on 2 October 2019 at 35,821.4 points, dipping do...

In afternoon trade the S&P/ASX 200 index has followed the lead of U.S. markets and is on course to record a disappointing decline. At the time of writing the benchmark index is down 1.3% to 6,656.8 points. Four shares that have defied...

It is not often that headlines on the ASX really stand out. Aside from the obvious mining hits, tech partnerships and biotech results, most of the announcements released via the ASX’s platform each day read “daily share buyback notice”, “ap...

The CLINUVEL Pharmaceuticals Limited (ASX: CUV) share price has pushed higher on Wednesday after it provided an update on its SCENESSE product. In late morning trade the shares of the skin disorder-focused global biopharmaceutical company...